Skip to content

ARTELO BIOSCIENCES, INC.: 10-Q filed 2019-07-15

What ARTELO BIOSCIENCES, INC. reported in its quarterly report filed 2019-07-15 (fiscal Q3 2019): 31 published measures, 98 facts as tagged in accession 0001640334-19-001361.

This filing

Form
10-Q (quarterly report)
Filed
2019-07-15
Fiscal period
fiscal Q3 2019
Accession
0001640334-19-001361 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ARTELO BIOSCIENCES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2019-05-311,153,252USD
At 2018-08-31396,998USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2019-05-31134,379USD
At 2019-02-28-692,174USD
At 2018-11-30-475,164USD
At 2018-08-31-134,974USD
At 2018-05-31-91,345USD
At 2018-02-28215,175USD
At 2017-11-30294,006USD
At 2017-08-31544,837USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2019-05-31286,439USD
At 2018-08-31337,424USD
At 2018-05-31326,023USD
At 2017-08-31572,775USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-03-01 to 2019-05-31-344,883USD92
2018-09-01 to 2019-05-31-1,326,575USD273
2018-12-01 to 2019-02-28-424,789USD90
2018-09-01 to 2018-11-30-556,903USD91
2018-03-01 to 2018-05-31-577,857USD92
2017-09-01 to 2018-05-31-1,653,378USD273
2017-12-01 to 2018-02-28-798,464USD90
2017-09-01 to 2017-11-30-277,057USD91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2018-09-01 to 2019-05-31-1,731,580USD273
2017-09-01 to 2018-05-31-1,096,148USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2018-09-01 to 2019-05-311,679,772USD273
2017-09-01 to 2018-05-31862,656USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2018-09-01 to 2019-05-31-688USD273
2017-09-01 to 2018-05-31-887USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2019-05-31-3,965,155USD
At 2018-08-31-2,638,580USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2019-03-01 to 2019-05-312,058,929shares92
2018-09-01 to 2019-05-311,898,263shares273
2018-03-01 to 2018-05-311,592,635shares92
2017-09-01 to 2018-05-311,493,713shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2019-03-01 to 2019-05-312,267,655shares92
2018-09-01 to 2019-05-312,142,959shares273
2018-03-01 to 2018-05-311,592,635shares92
2017-09-01 to 2018-05-311,493,713shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2019-03-01 to 2019-05-31-0.17USD/shares92
2018-09-01 to 2019-05-31-0.7USD/shares273
2018-03-01 to 2018-05-31-0.36USD/shares92
2017-09-01 to 2018-05-31-1.11USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2019-03-01 to 2019-05-31-0.4USD/shares92
2018-09-01 to 2019-05-31-1.04USD/shares273
2018-03-01 to 2018-05-31-0.36USD/shares92
2017-09-01 to 2018-05-31-1.11USD/shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2019-03-01 to 2019-05-310USD92
2018-09-01 to 2019-05-310USD273
2018-03-01 to 2018-05-310USD92
2017-09-01 to 2018-05-310USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2019-05-31857USD
At 2018-08-31563USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2018-09-01 to 2019-05-31376,095USD273
2017-09-01 to 2018-05-31168,751USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2019-03-01 to 2019-05-31-941,288USD92
2018-09-01 to 2019-05-31-2,256,110USD273
2018-03-01 to 2018-05-31-577,857USD92
2017-09-01 to 2018-05-31-1,653,378USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2019-05-311,152,395USD
At 2018-08-31396,435USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2019-05-311,018,873USD
At 2018-08-31531,972USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2019-03-01 to 2019-05-31941,288USD92
2018-09-01 to 2019-05-312,256,110USD273
2018-03-01 to 2018-05-31577,857USD92
2017-09-01 to 2018-05-311,653,378USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2019-03-01 to 2019-05-31184,204USD92
2018-09-01 to 2019-05-31858,224USD273
2018-03-01 to 2018-05-31236,845USD92
2017-09-01 to 2018-05-31917,388USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2019-05-312,101,140shares
At 2018-08-311,750,268shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2019-05-314,107,660USD
At 2018-08-312,514,136USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2019-05-31-10,227USD
At 2018-08-31-12,280USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2019-05-31646USD
At 2018-08-31282USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2019-03-01 to 2019-05-31-344,112USD92
2018-09-01 to 2019-05-31-1,324,522USD273
2018-03-01 to 2018-05-31-587,919USD92
2017-09-01 to 2018-05-31-1,665,719USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2019-03-01 to 2019-05-31402,803USD92
2018-09-01 to 2019-05-31666,226USD273
2018-03-01 to 2018-05-31104,564USD92
2017-09-01 to 2018-05-31272,052USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2019-03-01 to 2019-05-31243USD92
2018-09-01 to 2019-05-31383USD273
2018-03-01 to 2018-05-3173USD92
2017-09-01 to 2018-05-31249USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2019-03-01 to 2019-05-31596,405USD92
2018-09-01 to 2019-05-31929,535USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2018-09-01 to 2019-05-310USD273
2017-09-01 to 2018-05-310USD273

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2018-09-01 to 2019-05-310USD273
2017-09-01 to 2018-05-310USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2018-09-01 to 2019-05-311,675,637USD273
2017-09-01 to 2018-05-31860,786USD273

Inspect the source

Entity
ARTELO BIOSCIENCES, INC. / CIK 0001621221
Captured
2026-09-21T17:20:46.444Z
SEC response SHA-256
8c305444d4d0d2c4ad293d87d813338ddd6341ab9515d1faff9d1e445f967777

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001621221.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))